Our Research Focus
The Journal of Breast Cancer Survival (JBCS) publishes peer-reviewed research elucidating the molecular mechanisms underlying breast cancer development, progression, and metastasis. We prioritize studies that reveal cellular pathways, identify novel biomarkers, characterize disease models, and advance mechanistic understanding of breast cancer pathophysiology.
As a specialized pathophysiology journal, JBCS bridges laboratory discovery with translational insights, fostering interdisciplinary collaboration among molecular biologists, cancer researchers, pathologists, and biochemists investigating the fundamental biological processes that drive breast cancer.
JBCS emphasizes mechanistic studies that illuminate how breast cancer develops and progresses at the molecular and cellular levels. Our editorial priorities center on pathophysiological mechanisms rather than clinical management protocols.
Signaling pathways, gene regulation networks, epigenetic modifications, post-translational modifications, and molecular drivers of tumorigenesis
Identification and validation of diagnostic, prognostic, and predictive biomarkers through genomic, proteomic, metabolomic, and transcriptomic approaches
Development and characterization of in vitro cell culture systems, organoids, xenografts, genetically engineered mouse models, and patient-derived models
Cell cycle dysregulation, apoptosis resistance, metabolic reprogramming, immune evasion mechanisms, and tumor microenvironment interactions
Epithelial-mesenchymal transition, invasion pathways, intravasation/extravasation processes, dormancy mechanisms, and organotropism
Germline and somatic mutations, copy number alterations, chromosomal instability, hereditary cancer syndromes, and molecular epidemiology
Molecular basis of chemoresistance, radioresistance, targeted therapy resistance, adaptive cellular responses, and bypass pathway activation
Intratumoral diversity, cancer stem cell populations, clonal evolution, spatial transcriptomics, and single-cell molecular profiling
JBCS maintains rigorous standards for experimental design, molecular methodologies, and data interpretation. We prioritize studies employing contemporary techniques and reproducible approaches.
- Cell line authentication and characterization
- Primary cell isolation and culture
- 3D culture systems and organoids
- Co-culture models and cell-cell interactions
- High-throughput screening platforms
- CRISPR/gene editing technologies
- Genetically engineered mouse models
- Patient-derived xenografts (PDX)
- Orthotopic and metastatic models
- Imaging and molecular tracking
- Pharmacodynamic assessments
- Tissue microenvironment analysis
- Next-generation sequencing (DNA, RNA, ChIP)
- Mass spectrometry and proteomics
- Flow cytometry and cell sorting
- Immunohistochemistry and tissue imaging
- Western blotting and protein arrays
- qRT-PCR and gene expression analysis
- Bioinformatics and systems biology
- Pathway enrichment analysis
- Network modeling and simulations
- Machine learning for biomarker discovery
- Integrative multi-omics analysis
- Database mining and meta-analysis
Open Access Visibility
All articles are immediately and permanently accessible worldwide, maximizing research impact and facilitating knowledge translation across disciplines and geographic boundaries.
Rapid Peer Review
Streamlined editorial workflow with expert reviewers ensures timely evaluation while maintaining rigorous scientific standards. Average time to first decision: 3-4 weeks.
Rigorous Quality Standards
Editorial board comprises leading breast cancer researchers who assess methodological rigor, experimental design, statistical analysis, and mechanistic insights.
Interdisciplinary Readership
Content reaches molecular biologists, cancer researchers, pathologists, geneticists, and translational scientists advancing breast cancer understanding.
Indexed & Discoverable
Articles are indexed in major scientific databases, ensuring long-term discoverability and citation potential within the research community.
- Original Research Articles: Novel mechanistic findings from in vitro or in vivo studies revealing breast cancer pathophysiology, including molecular pathway elucidation, biomarker characterization, and disease model development.
- Review Articles: Comprehensive syntheses of current mechanistic knowledge on specific aspects of breast cancer biology, integrating recent discoveries and identifying knowledge gaps.
- Short Communications: Preliminary mechanistic findings, novel experimental approaches, or significant observations that advance understanding of breast cancer pathophysiology.
- Methods & Protocols: Detailed descriptions of innovative experimental techniques, model systems, or analytical approaches for studying breast cancer mechanisms.
- Case Studies: Detailed molecular characterization of rare tumor subtypes or unusual pathophysiological presentations with mechanistic insights.
JBCS is guided by an international editorial board of distinguished researchers specializing in breast cancer pathophysiology, molecular biology, and translational research.
I was impressed by the swift services of the journal and easy navigation beginning from manuscript submission to galley proof. I would recommend future authors - "Consider this journal if you are wondering where to publish your scientific work". They are Google Scholar indexed and so you do not have to worry if your scientific work won't reach the community of other researchers.
Long Island University
Our experience working with OPEN ACCESS PUB is excellent. I strongly recommend to specialists on neurology and neuroscience to publish their research studies in this open access journal.
Biological Research Institute
Authors should carefully review the Instructions for Authors before manuscript preparation. All submissions must be in English and should emphasize mechanistic insights, experimental rigor, and reproducibility.
Publish Your Breast Cancer Research
Join the community of researchers advancing molecular understanding of breast cancer pathophysiology. JBCS provides a rigorous, open access platform for mechanistic discoveries that shape the future of cancer research.
